Categories: News

BingX Launches $150M Shield Fund to Set a New Benchmark for User Protection

PANAMA CITY, June 5, 2025 /PRNewswire/ — BingX, a leading global cryptocurrency exchange and Web3 AI company, has introduced the Shield Fund, a permanent $150 million safety reserve dedicated to safeguarding users against unforeseen cyber threats and extreme market volatility. Unlike conventional insurance models, the Shield Fund is entirely self-funded and always active, enabling BingX to respond swiftly during crises. This initiative underscores BingX’s commitment to transparency, accountability, and its unwavering user-first vision.

- Advertisement -

Built with long-term sustainability in mind, the Shield Fund features continuous internal audits and dynamic risk assessments to adapt to evolving market conditions. It offers BingX users an added layer of real-time protection and peace of mind, solidifying BingX’s position as a leader in secure and responsible crypto trading.

- Advertisement -

“The launch of the BingX Shield Fund is a strategic extension of our user-first vision. It is not simply a financial safeguard — it is a symbol of how we view responsibility at scale,” said Vivien Lin, Chief Product Officer at BingX. “We are reaffirming our commitment to building a secure, transparent, and forward-thinking trading environment. As our platform grows, so does our duty to empower users with tools and systems that ensure confidence, resilience, and long-term trust.”

- Advertisement -

Following the implementation of Proof-of-Reserve, the Shield Fund represents the next chapter in BingX’s ongoing mission to elevate platform integrity and user protection. Together, these initiatives form a robust foundation for a more transparent, secure, and accountable trading environment. Looking ahead, BingX remains committed to delivering proactive safety measures and pioneering infrastructure innovations to safeguard user interests.

- Advertisement -

About BingX 

- Advertisement -

Founded in 2018, BingX is a leading crypto exchange and Web3 AI company, serving a global community of over 20 million users. With a comprehensive suite of AI-powered products and services, including derivatives, spot trading, and copy trading, BingX caters to the evolving needs of users across all experience levels, from beginners to professionals. Committed to building a trustworthy and intelligent trading platform, BingX empowers users with innovative tools designed to enhance performance and confidence. In 2024, BingX proudly became the official crypto exchange partner of Chelsea Football Club, marking an exciting debut in the world of sports sponsorship.

- Advertisement -

For more information please visit: https://bingx.com/

- Advertisement -

Photo – https://mma.prnewswire.com/media/2704170/1280_675_blank.jpg 
Logo – https://mma.prnewswire.com/media/2310183/BingX_logo_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/bingx-launches-150m-shield-fund-to-set-a-new-benchmark-for-user-protection-302474266.html

- Advertisement -

Recent Posts

FemiCore (Official Website & Authenticity Notice 2026) Counterfeit Risks and What Consumers Should Know

New York City, NY, June 13, 2026 (GLOBE NEWSWIRE) -- The women's health supplement market…

2 hours ago

Hitch Open Ping-Pong Embodied (HOPE) AI Challenge Joins the 2026 World Humanoid Robot Games, Seeding Advanced Physical AI Against Human Performance

BEIJING, June 13, 2026 (GLOBE NEWSWIRE) -- The 2026 Hitch Open Ping-Pong Embodied AI Challenge…

2 hours ago

Crypto News Today: AlphaPepe Unveils AlphaSwap Early Access as Bitcoin Price Prediction Eyes $250,000

MONACO, June 12, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe after…

2 hours ago

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies [NSE: HEXT], a…

4 hours ago

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI…

5 hours ago

Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

June 13, 2026 07:30 ET  | Source: Intellia Therapeutics, Inc. Data from HAELO Phase 3…

5 hours ago